Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501).

Francois, Fabien; Naimi, Loubna; Roblin, Xavier; Berger, Anne-Emmanuelle; Paul, Stephane

Francois, Fabien; Naimi, Loubna; Roblin, Xavier; Berger, Anne-Emmanuelle; Paul, Stephane.

Affiliation

Francois F; Department of Immunology, CIC1408, GIMAP U1111/UMR5308 INSERM-UJM-UCBL-ENS de Lyon-CNRS, University Hospital of Saint-Etienne, Saint-Etienne, France.
Naimi L; Department of Immunology, CIC1408, GIMAP U1111/UMR5308 INSERM-UJM-UCBL-ENS de Lyon-CNRS, University Hospital of Saint-Etienne, Saint-Etienne, France.
Roblin X; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France.
Berger AE; Department of Immunology, CIC1408, GIMAP U1111/UMR5308 INSERM-UJM-UCBL-ENS de Lyon-CNRS, University Hospital of Saint-Etienne, Saint-Etienne, France.
Paul S; Department of Immunology, CIC1408, GIMAP U1111/UMR5308 INSERM-UJM-UCBL-ENS de Lyon-CNRS, University Hospital of Saint-Etienne, Saint-Etienne, France. stephane.paul@chu-st-etienne.fr.

BMC Immunol ; 22(1): 81, 2021 12 25.

Article in En | MEDLINE | ID: mdl-34953484

Subject(s)

Biosimilar Pharmaceuticals; Colitis, Ulcerative; Adalimumab/pharmacology; Adalimumab/therapeutic use; Biosimilar Pharmaceuticals/pharmacology; Biosimilar Pharmaceuticals/therapeutic use; Drug Monitoring/methods; Humans; Immunoassay

Key words

ABP501; AMGEVITA; Adalimumab; Anti-TNFα; Biosimilar; Drug monitoring; HUMIRA

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Colitis, Ulcerative / Biosimilar Pharmaceuticals Limits: Humans Language: En Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Colitis, Ulcerative / Biosimilar Pharmaceuticals Limits: Humans Language: En Year: 2021 Type: Article